Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
publishDate:"[2022 TO 2022]"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=publishDate%3A%22%5B2022+TO+2022%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=11
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=publishDate%3A%22%5B2022+TO+2022%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=11
Search /vufind/Search2/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=publishDate%3A%22%5B2022+TO+2022%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=11
PubPharm (236)
101
COVERS (COVID-Vaccination Efficiency Risk and Safety Study) : COVERS (COVID-Vaccination Efficiency Risk and Safety Study)- an open trial for follow-up of efficacy, risk and safety in persons who have been vaccinated against SARS-CoV-2 in Region Skåne with vaccines approved in Sweden
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
102
Novel AIC649 in otherwise healthy patients with asymptomatic or mildly symptomatic SARS-CoV-2 Infection : A randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of AIC649 in the treatment of otherwise healthy subjects with asymptomatic or mildly symptomatic SARS-CoV-2 infection
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
103
study to prevent disease progression in hospitalised non-intubated COVID-19 patients by treatment with FX06 : Potential of FX06 to prevent disease progression in hospitalised non-intubated COVID-19 patients (Ixion) - IXION
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
104
Reparixin 1200 mg three times a day as add-on therapy to standard of care to limit disease progression in hospitalised adult patients with COVID-19 : Reparixin 1200 mg three times a day as add-on therapy to standard of care to limit disease progression in hospitalised adult patients with COVID-19. A multinational, multicentre, randomised, double blinded, placebo-controlled, parallel-group phase III trial. - REP0321 Fase 3
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
105
Adrecizumab to improve prognosis and outcomes in covid-19 trial : Multicenter, randomized, double-blind, biomarker-guided, phase II trial with Adrecizumab (HAM 8101) to improve proGNosis and outcomES in patients with moderate to severe covid-19 - Adrecizumab (HAM8101) to improve proGNosis and outcomES in covid-19 Trial - AGNES-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
106
Safety and immunological response against SARS-CoV-2 after revaccination with mRNA-1273 with a ceramic skin patch : Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers - MILESTONE: iMmunogenicity IntradermaL cEramic Skin paTch sars-cOv-2 vacciNE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
107
CCR1 antagonist treatment in patients hospitalized with COVID-19A multi-centric, randomized, double-blind, and placebo-controlled clinical phase II trial : CCR1 antagonist treatment in patients hospitalized with COVID-19A multi-centric, randomized, double-blind, and placebo-controlled clinical phase II trial - CATCOVID
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
108
Etude de preuve de concept de phase IIB, multicentrique, en double aveugle, randomisée, contrôlée versus placebo, évaluant le diltiazem en association avec le traitement standard dans la prise en charge de patients hospitalisés pour pneumopathie à COVID-19 : Etude de preuve de concept de phase IIB, multicentrique, en double aveugle, randomisée, contrôlée versus placebo, évaluant le diltiazem en association avec le traitement standard dans la prise en charge de patients hospitalisés pour pneumopathie à COVID-19 - DICOV
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
109
COVERS (COVID-Vaccination Efficiency Risk and Safety Study) : COVERS (COVID-Vaccination Efficiency Risk and Safety Study)- an open trial for follow-up of efficacy, risk and safety in persons who have been vaccinated against SARS-CoV-2 in Region Skåne with vaccines approved in Sweden
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
110
Novel AIC649 in otherwise healthy patients with asymptomatic or mildly symptomatic SARS-CoV-2 Infection : A randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of AIC649 in the treatment of otherwise healthy subjects with asymptomatic or mildly symptomatic SARS-CoV-2 infection
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
[1]
« Vorheriger
6
7
8
9
10
11
12
13
14
15
16
Nächster »
[24]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Erscheinungsjahr: 2022-2022
Medienart
236
Aufsätze
236
E-Artikel
236
E-Ressourcen
Zeitschriftentitel
236
WHO International Clinical Trials Registry Plat...
Thema
236
610
236
Recruitment Status: Authorised-recruitment may ...
236
Study Type: Interventional
122
Phase: Phase 2
50
Phase: Phase 3
44
Phase: Phase 4
20
Phase: Phase 1
14
Medical Condition: Protection against COVID-19 ...
8
Medical Condition: Acute respiratory distress s...
8
Medical Condition: Coronavirus Disease 2019 (CO...
6
Medical Condition: Prevention of COVID-19 infec...
6
Medical Condition: Severe Acute Respiratory Syn...
6
Medical Condition: Severe COVID-19 MedDRA versi...
6
Medical Condition: moderate COVID-19 infection ...
4
Medical Condition: Adult hospitalized patients ...
4
Medical Condition: COVID-19 development in hosp...
4
Medical Condition: COVID-19;Therapeutic area: D...
4
Medical Condition: Coronavirus disease 2019 (CO...
4
Medical Condition: Coronavirus disease 2019 (CO...
4
Medical Condition: Coronavirus disease 2019 (CO...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2022-2022
Erscheinungsjahr(e)
Von:
Bis:
Sprache
230
Englisch
4
Unbestimmt
2
Französisch
Haven't found what you're looking for?
Wird geladen...